|
DSM SOMOS® ANNOUNCES FULL COMMERCIALIZATION OF NANOFORM™ 15120 AFTER SUCCESSFUL GLOBAL BETA TESTING
01 November 2004 - DSM Somos
| DSM Somos has announced the full commercialization of NanoForm™ 15120 after nearly one year of successful, comprehensive beta testing by a variety of industries and stereolithography (SL) service bureaus worldwide. |
NanoForm 15120 is a composite stereolithography material which incorporates non-crystalline nano-particle technology for enhanced performance properties, including exceptionally high stiffness and heat resistance. Heat deflection temperatures of more than 500°F (265°C) have been reported. 'The composite technology of NanoForm contributes to exceptional dimensional stability, low shrink, and low coefficient of thermal linear expansion,' says DSM Somos Application Development & Technical Service Manager Matt Cantwell. 'This material offers a unique alternative to previous stereolithography and selective laser sintering solutions available on the market. It is processed in an identical manner to unreinforced liquid SL resins, requiring no mixing or other special handling.' NanoForm was first introduced at the Frankfurt Euromold fair in December 2003. 'Since that time, numerous companies have been successfully implementing it into their material offerings for medical, automotive and aerospace applications,' states DSM Somos Marketing and Sales Manager Ty Bacon. Marc Lesko, Rapid Prototyping Product Designer for ConvaTec (leader in ostomy and wound care products) says, 'I've successfully used the Nanoform resin to produce vacuum form molds and lab test fixtures. Its high temperature and hardness properties make it very useful for rapid prototyping and this resin has helped to speed the development process.'
http://www.dsmsomos.com
About: DSM Somos
DSM Somos is an unincorporated division of DSM Desotech—a world leader in the development of UV-curable materials—and a member of the global DSM family.
DSM Somos is currently the world's second largest materials supplier to the rapid prototyping industry, providing stereolithography liquids and
selective laser sintering powders used for the creation of three dimensional models and prototypes directly from digital data. Somos' patented ProtoFunctional materials are used by a variety of industries, including automotive, aerospace, medical and telecommunications. DSM Somos has developed a full line of rapid prototyping materials that replicate the performance parameters of production materials, saving both time and money in new product development. From thermoplastic elastomers to polyethylene and polypropylene, DSM Somos has stereolithography and selective laser sintering technologies. The Somos business has been actively involved in the development of rapid prototyping materials since the late 1980s, from the introduction of the first commercial Somos stereolithography resin in 1992. DSM Somos is part of DSM Desotech, a leading innovative formulator and manufacturer of high quality ultraviolet and electron beam (UV/EB) curable materials. DSM Desotech is a business unit of DSM - an international chemicals and materials group headquartered in The Netherlands, with annual sales of EUR 8.1 billion and a work force of approximately 22,000 employees at more than 200 sites worldwide. DSM is active worldwide in life science and nutritional products, performance materials and industrial chemicals. The company specializes in innovative products and services that help improve the quality of life and DSM products are currently used in a wide range of end markets and applications such as human and animal nutrition and health, cosmetics, pharmaceuticals, automotive and transport, coatings, housing and electrics & electronics (E&E). The group has annual sales (pro forma including the recent acquisition - renamed DSM Nutritional Products) of approximately EUR 8 billion and employs about 26,000 people around the world. Ranking among the global leaders in many of its fields, DSM is headquartered in the Netherlands, with locations in Europe, Asia and the Americas. |
More News:
• For November 2004
• From DSM Somos
• For General
|
